Nihon Trim (6788) · TargetAchieved
Transition to the Tokyo Stock Exchange Prime Market
First written in FY2022-Q3. 1 of 2 entries say "Achieved", first in FY2022. Latest entry: FY2022.
2entries
1years
0from disclosures
How it moved
Same theme, other companies
Transition to the Tokyo Stock Exchange Prime MarketA theme 115 companies write about · 0 as a headwind · 20 as a tailwind
22 other companies' latest entry also says "Achieved".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 115 companies compared. The sentences above are computed from all 115.Full recordFilings, disclosures and news, newest first
- FY2022AchievedAnnual report
「Following the Tokyo Stock Exchange’s review of its market segments on 4 April 2022, the company transferred from the First Section to the Prime Market, while StemCell Institute transferred from the Mothers Market to the Growth Market.」
The planned transfer to the Tokyo Stock Exchange Prime Market was completed on 4 April 2022. - FY2022-Q3First statedAnnual report
「As part of the Tokyo Stock Exchange’s market restructuring scheduled for 4 April this year, the company will transfer to the Prime Market.」
The planned transfer to the Tokyo Stock Exchange Prime Market on 4 April 2022 was presented for the first time as a separate topic.